Marco Falcone

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone Resistance

Patrick N. A. Harris, Paul Anantharajah Tambyah, David Chien Lye et al. · JAMA · 2018 · 770 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia

Carlo Salvarani, Giovanni Dolci, Marco Massari et al. · JAMA Internal Medicine · 2020 · 733 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study

Belén Gutiérrez‐Gutiérrez, Elena Salamanca, Marina de Cueto et al. · The Lancet Infectious Diseases · 2017 · 521 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase–Producing Enterobacterales

Marco Falcone, George L. Daikos, Giusy Tiseo et al. · Clinical Infectious Diseases · 2020 · 364 citations

Medicine, Infectious Diseases, Pharmacotherapy +13

Whole-genome sequencing reveals host factors underlying critical COVID-19

Athanasios Kousathanas, Erola Pairo‐Castineira, Konrad Rawlik et al. · Nature · 2022 · 347 citations · Full text

Life Sciences, Infectious Diseases, Molecular Genetics +17